Harris Todd's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Mar 28, 2023
- Accession no.
- 0001209191-23-021443
- Filed
- Mar 28, 2023
- Trade date
- Mar 24-28, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $94.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harris ToddCIK 0001711463 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2023 | Common Stock | MOption exerciseAcquired | +170 | $2.25 | +$382.5 | 1,701,446 | Direct | |
| Mar 24, 2023 | Common Stock | SSaleDisposed | −170 | $16.00 | −$2,720 | 1,701,276 | Direct | |
| Mar 27, 2023 | Common Stock | MOption exerciseAcquired | +2,963 | $2.25 | +$6,666.75 | 1,704,239 | Direct | |
| Mar 27, 2023 | Common Stock | SSaleDisposed | −2,963 | $16.00 | −$47,408 | 1,701,276 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseAcquired | +2,779 | $2.25 | +$6,252.75 | 1,704,055 | Direct | |
| Mar 28, 2023 | Common Stock | SSaleDisposed | −2,779 | $16.00 | −$44,464 | 1,701,276 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2023 | Common Stock | MOption exerciseDisposed | −170 | $0.00 | $0 | 409,606 | Direct | |
| Mar 27, 2023 | Common Stock | MOption exerciseDisposed | −2,963 | $0.00 | $0 | 406,643 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −2,779 | $0.00 | $0 | 403,864 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.